![\"\"\/](\"https:\/\/www.medtechdive.com\/static\/img\/play.svg?500116090725\")
\n Listen to the article
\n 2 min<\/p>\n
\n Listen to the article
\n 2 min<\/p>\n
This audio is auto-generated. Please let us know if you have feedback<\/a>.<\/p>\n Dive Brief:<\/p>\n The U.S. president of Johnson & Johnson\u2019s orthopedics business is leaving as the company works to spin out the segment. Dive Insight:<\/p>\n J&J named Namal Nawana as worldwide president of its orthopedics business, DePuy Synthes, in October. The appointment put the former Smith & Nephew CEO in charge of leading DePuy during and after its separation from J&J.<\/p>\n Nawana will need to manage that process without the input of Storms. The departing executive said in a post published in late November that she was leaving J&J.<\/p>\n When J&J disclosed the spinout plan, analysts including Needham\u2019s Mike Matson said DePuy\u2019s rivals could initially benefit<\/a> from the separation. Ultimately, though, the analysts expect the separation to strengthen DePuy.<\/p>\n Storms wrote that she leaves J&J \u201c\u2018prepped\u2019 for my next chapter.\u201d She started a new role Monday as president of <\/a>Ethos Veterinary Health<\/a>, a network of specialty and emergency care facilities under National Veterinary Associates.\u00a0<\/p>\n While Storms most recently worked in orthopedics, she has held jobs in other areas of the medtech industry over the past decade.\u00a0Before taking on the orthopedics role, Storms spent five years in J&J\u2019s surgery unit and held the title of president of the U.S. business. Storms worked in J&J\u2019s vision business, which sells devices such as contact lenses and laser refractive surgery machines, before joining the surgery unit.<\/p>\n","protected":false},"excerpt":{"rendered":"Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback.…\n","protected":false},"author":2,"featured_media":327588,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":{"0":"post-327587","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-healthcare"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/327587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=327587"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/327587\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/327588"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=327587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=327587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=327587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nLeslie Storms shared details<\/a> of her departure in a LinkedIn post last week. Storms worked at J&J for 18 years, culminating in an almost three-year stint as U.S. head of its orthopedics business.
\nNews of Storms\u2019 departure comes six weeks after J&J committed<\/a> to spinning out its orthopedics business to create a standalone company that would compete with firms like Stryker and Zimmer Biomet.<\/p>\n